Create an Account
Welcome & Mission Statement
User Technical Support
Accreditation Legend
System Requirements
7th International Symposium on Malignant Pleural Mesothelioma
Activity Details
Activity Name: 7th International Symposium on Malignant Pleural Mesothelioma
Needs Assessment:

Malignant pleural mesothelioma (MPM) is an unusual cancer because it grows throughout the chest cavity as a diffuse process rather than a typical solid nodule or mass. Because of this unique characteristic, it has very specific treatment issues. MPM also is a rare tumor with less than 3,000 new cases annually, and therefore, most physicians, even pulmonologists and medical oncologists, typically only see these patients infrequently. Despite this, it is critical that all physicians involved in the care of MPM patients be familiar with the important issues in this disease and possess a thorough understanding regarding the tumor itself, its evaluation process, staging, treatment and the role of multidisciplinary management of these patients. This includes the role and extent of surgery as well as radiation, chemotherapy and newer targeted therapies and immunotherapy. Robert B. Cameron, MD, the course organizer and the Director of the UCLA Comprehensive Mesothelioma Program, has had over 30 years of experience with treating patients with MPM, including pleurectomy and decortication surgical procedures and a number of complementary adjuvant therapies with the goal of treating this deadly disease like a chronic illness, similar to hypertension and diabetes.

Target Audience

  • Pulmonary physicians who are frequently involved in patient workups
  • Medical oncologists who are frequently involved in patient therapy
  • Mesothelioma experts who want to learn/share experiences about lung-sparing therapies
  • Patients, family and friends who desire to learn more about the disease
Course Objectives:

At the completion of this course, participants should be able to:

  • Describe the current role of each traditional modality in multidisciplinary therapies, including surgery, radiation, and chemotherapy
  • Name the possibilities for intraoperative adjuvant therapies
  • Review the nature of MPM and the need for chronic treatment
  • Cite the various types of biological and immunological therapies and their potential role in therapy
Location Information
Meeting Location: UCLA Meyer & Renee Luskin Conference Center
Meeting Location URL:
Location Address: 425 Westwood Plaza
Location City: Los Angeles
Location State: CA
Location Postal Code: 90095
Location Country: US
Activity Information
Start Date: 9/30/2017
End Date: 9/30/2017
Fees: Pre-registration fee (before September 6):

  • $150.00 - Physicians
  • $100.00 - Nurses
  • $75.00 - Family Members & Patients
  • $25.00 - Students*
  • $400.00 - Legal Profession

Late registration fee (starting September 6):

  • $225.00 - Physicians
  • $150.00 - Nurses
  • $100.00 - Family Members & Patients
  • $40.00 - Students*
  • $650.00 - Legal Profession
Meeting URL:
Printable Materials:
Credit Information
Credit Amount: 7.5
Credit Unit: Credits
Accreditation: ACCME - Accreditation Council for Continuing Medical Education > AMA PRA Category 1 Credit
Activity Learning Format: Live Activity
Sponsor Name: David Geffen School of Medicine at UCLA Office of Continuing Medical Education
Sponsor Address: 10920 Wilshire Blvd., Suite 1060
Sponsor City: Los Angeles
Sponsor State: CA
Sponsor Postal Code: 90024
Sponsor Country: US
Contact Information
Contact Name: Eloisa Ayala
Contact Address: 10920 Wilshire Blvd., Suite 1060
Contact City: Los Angeles
Contact State: CA
Contact Postal Code: 90024
Contact Country: US
Contact Phone: 310-794-2620
Contact Email:

Type:     Live Activity
0 Registered Users